Molecular Identification of HTLV-1 and HCV Infections in Sickle Cell Disease Patients Undergoing Multiple Transfusions in Kinshasa: A Case Study of CMMASS - Scorecard - MDSpire

Molecular Identification of HTLV-1 and HCV Infections in Sickle Cell Disease Patients Undergoing Multiple Transfusions in Kinshasa: A Case Study of CMMASS

  • By

  • Alain Kabongo Katamba Ilunga

  • Chloé Kayembe Musuamba

  • Cagod Inkale

  • Tarcise Kilara

  • Isaac Woto

  • Berry Ikolango Bongenya

  • Gisele Kasanka Kabengele

  • Baudouin Buassa

  • Dieudonné Tshipukane Nyembue

  • Benoit Obel Kabengele

  • Erick Ntambwe Kamangu

  • January 22, 2026

  • 0 min

Share

Clinical Scorecard: Molecular Identification of HTLV-1 and HCV Infections in Sickle Cell Disease Patients Undergoing Multiple Transfusions in Kinshasa: A Case Study of CMMASS

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPolytransfused sickle cell patients in Kinshasa, aged over 5 years, with a focus on those aged 16-25.
Care Setting

Key Highlights

  • Include HTLV-1 prevalence data among the studied patients.

Guideline-Based Recommendations

Diagnosis

  • Use molecular biology techniques (RT-PCR, sequencing) for diagnosing HTLV-1 and HCV.

Management

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Management often requires multiple blood transfusions, increasing infection risk, particularly in the 16-25 age group.

        Clinical Best Practices

        • Conduct thorough screening for viral infections before blood transfusions, emphasizing the importance of molecular testing.

        References

        Original Source(s)

        Molecular Identification of HTLV-1 and HCV Infections in Sickle Cell Disease Patients Undergoing Multiple Transfusions in Kinshasa: A Case Study of CMMASS

        • by Alain Kabongo Katamba Ilunga, Chloé Kayembe Musuamba, Cagod Inkale, Tarcise Kilara, Isaac Woto, Berry Ikolango Bongenya, Gisele Kasanka Kabengele, Baudouin Buassa, Dieudonné Tshipukane Nyembue, Benoit Obel Kabengele, Erick Ntambwe Kamangu

        • January 22, 2026

        Related Content

        Clinical Findings in Migrants With Asymptomatic Plasmodium Infections

        Utilizing Erythrocyte Lifespan as a Predictor for Moderate to Severe Anemia in Patients with Advanced Gastric Cancer Following Anti-Tumor Treatments: A Prospective Investigation

        Merging evans syndrome with mucopolysaccharidosis type II: a case report